CAS: 2141-17-5 - 4-Hydroxytestosterone
Fórmula:C19H28O3
InChI:InChI=1S/C19H28O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,16,21-22H,3-10H2,1-2H3/t11-,12-,13-,16-,18+,19-/m0/s1
Clave InChI:InChIKey=BQOIJSIMMIDHMO-FBPKJDBXSA-N
SMILES:O=C1C(O)=C2CCC3C(CCC4(C)C(O)CCC34)C2(C)CC1
- Sinónimos:
- (17β)-4,17-Dihydroxyandrost-4-en-3-one
- 4,17beta-Dihydroxy-4-androstene-3-one
- 4-Hydroxytestosterone
- Androst-4-En-3-One, 4,17-Dihydroxy-, (17Beta)-
- Androst-4-en-3-one, 4,17-dihydroxy-, (17β)-
- Androst-4-en-3-one, 4,17β-dihydroxy-
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
4-Hydroxy Testosterone REF: TR-H956745CAS: 2141-17-5 | - - - | 222,00 €~2.451,00 € | Lun 02 Dic 24 | |
4-Hydroxy Testosterone (1.0mg/ml in Acetonitrile) REF: TR-KIT5305CAS: 2141-17-5 | - - - | 1.060,00 € | Jue 02 Ene 25 | |
4-Hydroxy testosterone REF: 3D-CAA14117CAS: 2141-17-5 | Min. 95% | 172,00 €~1.624,00 € | Vie 03 Ene 25 |
4-Hydroxy Testosterone
Producto controladoCAS:2141-17-5
Applications 4-Hydroxytestosterone is an anabolic steroid and does not have any therapeutic indication. 4-Hydroxytestosterone is …
Fórmula:
C19H28O3
Forma y color:
Neat
Peso molecular:
304.42
Ref: TR-H956745
1mg | 222,00 € | ||
25mg | 368,00 € | ||
250mg | 2.451,00 € |
Entrega estimada en Estados Unidos, el Lunes 2 de Diciembre de 2024
4-Hydroxy Testosterone (1.0mg/ml in Acetonitrile)
Producto controladoCAS:2141-17-5
Fórmula:
C19H28O3
Forma y color:
Single Solution
Peso molecular:
304.42
Ref: TR-KIT5305
1x1ml | 1.060,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Enero de 2025
4-Hydroxy testosterone
Producto controladoCAS:2141-17-5
Please enquire for more information about 4-Hydroxy testosterone including the price, delivery time and more …
Fórmula:
C19H28O3
Pureza:
Min. 95%
Peso molecular:
304.4 g/mol
Ref: 3D-CAA14117
1mg | 172,00 € | ||
5mg | 364,00 € | ||
10mg | 518,00 € | ||
25mg | 986,00 € | ||
50mg | 1.624,00 € |
Entrega estimada en Estados Unidos, el Viernes 3 de Enero de 2025